Logo image of CRWN-NT.CA

Crown Capital Partners Inc (CRWN-NT.CA) Stock Fundamental Analysis

TSX:CRWN-NT - Toronto Stock Exchange - - Currency: CAD

22.25  0 (0%)

Fundamental Rating

2

Overall CRWN-NT gets a fundamental rating of 2 out of 10. We evaluated CRWN-NT against 82 industry peers in the Capital Markets industry. CRWN-NT may be in some trouble as it scores bad on both profitability and health. CRWN-NT is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CRWN-NT had negative earnings in the past year.
CRWN-NT had a positive operating cash flow in the past year.
CRWN-NT had negative earnings in 4 of the past 5 years.
In the past 5 years CRWN-NT always reported a positive cash flow from operatings.
CRWN-NT.CA Yearly Net Income VS EBIT VS OCF VS FCFCRWN-NT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

CRWN-NT has a Return On Assets of -21.03%. This is amonst the worse of the industry: CRWN-NT underperforms 85.37% of its industry peers.
CRWN-NT's Return On Equity of -443.62% is on the low side compared to the rest of the industry. CRWN-NT is outperformed by 89.02% of its industry peers.
With a Return On Invested Capital value of 1.71%, CRWN-NT is not doing good in the industry: 70.73% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -21.03%
ROE -443.62%
ROIC 1.71%
ROA(3y)-10.46%
ROA(5y)-6.81%
ROE(3y)-129.97%
ROE(5y)-80.67%
ROIC(3y)N/A
ROIC(5y)N/A
CRWN-NT.CA Yearly ROA, ROE, ROICCRWN-NT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

With a Operating Margin value of 2.92%, CRWN-NT is not doing good in the industry: 74.39% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of CRWN-NT has declined.
CRWN-NT has a better Gross Margin (42.42%) than 65.85% of its industry peers.
In the last couple of years the Gross Margin of CRWN-NT has declined.
Industry RankSector Rank
OM 2.92%
PM (TTM) N/A
GM 42.42%
OM growth 3Y-54.1%
OM growth 5Y-48.32%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.85%
GM growth 5Y-14.71%
CRWN-NT.CA Yearly Profit, Operating, Gross MarginsCRWN-NT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

2

2. Health

2.1 Basic Checks

The number of shares outstanding for CRWN-NT remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CRWN-NT has less shares outstanding
CRWN-NT has a worse debt/assets ratio than last year.
CRWN-NT.CA Yearly Shares OutstandingCRWN-NT.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CRWN-NT.CA Yearly Total Debt VS Total AssetsCRWN-NT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CRWN-NT has an Altman-Z score of 0.47. This is a bad value and indicates that CRWN-NT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CRWN-NT (0.47) is comparable to the rest of the industry.
The Debt to FCF ratio of CRWN-NT is 5.12, which is a neutral value as it means it would take CRWN-NT, 5.12 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 5.12, CRWN-NT is doing good in the industry, outperforming 65.85% of the companies in the same industry.
A Debt/Equity ratio of 5.61 is on the high side and indicates that CRWN-NT has dependencies on debt financing.
With a Debt to Equity ratio value of 5.61, CRWN-NT is not doing good in the industry: 89.02% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 5.61
Debt/FCF 5.12
Altman-Z 0.47
ROIC/WACCN/A
WACCN/A
CRWN-NT.CA Yearly LT Debt VS Equity VS FCFCRWN-NT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

CRWN-NT has a Current Ratio of 0.79. This is a bad value and indicates that CRWN-NT is not financially healthy enough and could expect problems in meeting its short term obligations.
CRWN-NT has a worse Current ratio (0.79) than 79.27% of its industry peers.
CRWN-NT has a Quick Ratio of 0.79. This is a bad value and indicates that CRWN-NT is not financially healthy enough and could expect problems in meeting its short term obligations.
CRWN-NT has a worse Quick ratio (0.75) than 79.27% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.75
CRWN-NT.CA Yearly Current Assets VS Current LiabilitesCRWN-NT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2

3. Growth

3.1 Past

CRWN-NT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -153.96%.
The Revenue has been growing slightly by 6.93% in the past year.
Measured over the past years, CRWN-NT shows a quite strong growth in Revenue. The Revenue has been growing by 14.85% on average per year.
EPS 1Y (TTM)-153.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-195.19%
Revenue 1Y (TTM)6.93%
Revenue growth 3Y18.67%
Revenue growth 5Y14.85%
Sales Q2Q%22.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y630.77%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRWN-NT.CA Yearly Revenue VS EstimatesCRWN-NT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
CRWN-NT.CA Yearly EPS VS EstimatesCRWN-NT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2023 2024 2025 0 0.5 -0.5 -1 -1.5 -2

4

4. Valuation

4.1 Price/Earnings Ratio

CRWN-NT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 31.61, which means the current valuation is very expensive for CRWN-NT.
CRWN-NT's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of CRWN-NT to the average of the S&P500 Index (36.80), we can say CRWN-NT is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 31.61
CRWN-NT.CA Price Earnings VS Forward Price EarningsCRWN-NT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

CRWN-NT's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, CRWN-NT is valued cheaply inside the industry as 80.49% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.74
EV/EBITDA 12.58
CRWN-NT.CA Per share dataCRWN-NT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

CRWN-NT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CRWN-NT!.
Industry RankSector Rank
Dividend Yield N/A

Crown Capital Partners Inc

TSX:CRWN-NT (7/29/2025, 7:00:00 PM)

22.25

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-13 2025-05-13
Earnings (Next)08-07 2025-08-07
Inst Owners31.26%
Inst Owner ChangeN/A
Ins Owners28.11%
Ins Owner ChangeN/A
Market Cap126.16M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 31.61
P/S 1.68
P/FCF 9.74
P/OCF 5.95
P/B 18.29
P/tB 33.07
EV/EBITDA 12.58
EPS(TTM)-5.47
EYN/A
EPS(NY)0.7
Fwd EY3.16%
FCF(TTM)2.28
FCFY10.27%
OCF(TTM)3.74
OCFY16.81%
SpS13.24
BVpS1.22
TBVpS0.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.03%
ROE -443.62%
ROCE 2.38%
ROIC 1.71%
ROICexc 1.84%
ROICexgc 1.91%
OM 2.92%
PM (TTM) N/A
GM 42.42%
FCFM 17.25%
ROA(3y)-10.46%
ROA(5y)-6.81%
ROE(3y)-129.97%
ROE(5y)-80.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-44.15%
ROICexcg growth 5Y-26.04%
ROICexc growth 3Y-44.82%
ROICexc growth 5Y-26.62%
OM growth 3Y-54.1%
OM growth 5Y-48.32%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.85%
GM growth 5Y-14.71%
F-Score4
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 5.61
Debt/FCF 5.12
Debt/EBITDA 2.62
Cap/Depr 65.53%
Cap/Sales 10.99%
Interest Coverage 0.52
Cash Conversion 143.36%
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.75
Altman-Z 0.47
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)43.75%
Cap/Depr(5y)42.25%
Cap/Sales(3y)6.83%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-153.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-195.19%
EPS Next Y630.77%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.93%
Revenue growth 3Y18.67%
Revenue growth 5Y14.85%
Sales Q2Q%22.47%
Revenue Next Year11.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y177.89%
EBIT growth 3Y-45.53%
EBIT growth 5Y-40.65%
EBIT Next Year957.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y471.09%
FCF growth 3Y38.54%
FCF growth 5Y25.25%
OCF growth 1Y4341.2%
OCF growth 3Y46.98%
OCF growth 5Y16.44%